OPRM1 and Alzheimer disease: This suggests that there might indeed be regional differences in the expression pattern of opioid receptors and that the dysregulation of opioidergic signaling (including, most likely, a prolonged, pathological activation of MOR at the periphery) may contribute to the development of itch in (at least a subset of) AD patients.